Rankings
▼
Calendar
NAUT
Nautilus Biotechnology, Inc.
$289M
Q3 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$178,000
Net Income
$617,205
EPS (Diluted)
$0.09
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$52,188
Free Cash Flow
-$52,188
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$148M
Total Liabilities
$143M
Stockholders' Equity
$5M
Cash & Equivalents
$963,318
← FY 2019
All Quarters
Q4 2019 →
NAUT Q3 2019 Earnings — Nautilus Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena
